Increased frequency of non-fumigatus Aspergillus species in amphotericin B– or triazole–pre-exposed cancer patients with positive cultures for aspergilli
Open Access
- 31 May 2005
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (1) , 15-20
- https://doi.org/10.1016/j.diagmicrobio.2005.01.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patientsJournal of Medical Microbiology, 2004
- Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative StudyJournal of Clinical Microbiology, 2002
- Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus SpeciesJournal of Clinical Microbiology, 2002
- E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution MethodJournal of Clinical Microbiology, 2002
- Why Prior Fluconazole Use Is Associated with an Increased Risk of Invasive Mold Infections in Immunosuppressed Hosts: An Alternative HypothesisClinical Infectious Diseases, 2002
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Antifungal drug resistance of pathogenic fungiThe Lancet, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous FungiJournal of Clinical Microbiology, 2001
- Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthaseAntimicrobial Agents and Chemotherapy, 1994